Rocket One (RKTO) Profit After Tax (2018 - 2026)
Rocket One's (RKTO) quarterly Profit After Tax came in at -$3.8 million in Q2 2026, down 74.39% year-over-year from -$15.0 million in Q2 2025, and down 42.46% quarter-over-quarter from -$2.7 million in Q1 2026.
Analysis
Rocket One (RKTO) Profit After Tax (2018 - 2026) Analysis & Trends
Rocket One has disclosed Profit After Tax across 9 years of filings, most recently posting -$3.8 million for Q2 2026.
- In Q2 2026, Profit After Tax fell 74.39% year-over-year to -$3.8 million; the TTM figure through Jun 2026 stood at -$13.3 million (down 32.92% YoY), while the FY2025 annual figure was -$12.5 million, down 51.94% from the prior year.
- Profit After Tax came in at -$3.8 million for Q2 2026 at Rocket One, down from -$2.7 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$1.7 million in Q2 2024 to a low of -$4.1 million in Q3 2025.
- Average Profit After Tax over 5 years is -$2.6 million, with a median of -$2.4 million recorded in 2022.
- Year-over-year, Profit After Tax jumped 48.35% in 2023 and plunged 84.24% in 2025.
- Over 5 years, Profit After Tax stood at -$3.5 million in 2022, then jumped by 48.35% to -$1.8 million in 2023, then slipped by 17.94% to -$2.1 million in 2024, then declined by 26.85% to -$2.7 million in 2025, then plunged by 42.69% to -$3.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$3.8 million in Q2 2026, -$2.7 million in Q1 2026, and -$2.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 2.38 Bn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | -10.50 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 1.10 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 1.30 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | 472.00 Mn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | -782.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | 97.50 Mn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | -290.61 Mn |
| 10 | Rocket One | 13.80 Mn | 5.90 Mn | - | -3.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.84 Mn |
| Mar 31, 2026 | -2.69 Mn |
| Dec 31, 2025 | -2.69 Mn |
| Sep 30, 2025 | -4.11 Mn |
| Jun 30, 2025 | -2.20 Mn |
| Mar 31, 2025 | -3.48 Mn |
| Dec 31, 2024 | -2.12 Mn |
| Sep 30, 2024 | -2.23 Mn |
| Jun 30, 2024 | -1.71 Mn |
| Mar 31, 2024 | -2.15 Mn |
| Dec 31, 2023 | -1.80 Mn |
| Sep 30, 2023 | -2.18 Mn |
| Jun 30, 2023 | -1.95 Mn |
| Mar 31, 2023 | -2.24 Mn |
| Dec 31, 2022 | -3.48 Mn |
| Sep 30, 2022 | -2.64 Mn |
| Jun 30, 2022 | -2.68 Mn |
| Mar 31, 2022 | -2.57 Mn |
| Dec 31, 2021 | -3.48 Mn |
| Sep 30, 2021 | -3.30 Mn |